These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 11859659

  • 1. [Urinary leukocytes as a new prognostic marker of therapeutic response and of adverse effects associated with the maintenance treatment with endovesical BCG, for the prophylaxis of superficial bladder tumors].
    Saint F, Irani J, Salomon L, Legrand P, Abbou CC, Chopin D.
    Prog Urol; 2001 Dec; 11(6):1242-50. PubMed ID: 11859659
    [Abstract] [Full Text] [Related]

  • 2. [Tolerance and efficiency of intravesical instillation of Calmette-Guérin in the prophylactic treatment of superficial bladder tumors, using a maintenance treatment].
    Saint F, Irani J, Salomon L, Debois H, Abbou CC, Chopin D.
    Prog Urol; 2001 Sep; 11(4):647-56. PubMed ID: 11761685
    [Abstract] [Full Text] [Related]

  • 3. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study.
    Colombel M, Saint F, Chopin D, Malavaud B, Nicolas L, Rischmann P.
    J Urol; 2006 Sep; 176(3):935-9. PubMed ID: 16890660
    [Abstract] [Full Text] [Related]

  • 4. The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder.
    Mack D, Höltl W, Bassi P, Brausi M, Ferrari P, de Balincourt C, Sylvester R, European Organization for Research and Treatment of Cancer Genitourinary Group.
    J Urol; 2001 Feb; 165(2):401-3. PubMed ID: 11176382
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
    Yossepowitch O, Eggener SE, Bochner BH, Donat SM, Herr HW, Dalbagni G.
    J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
    [Abstract] [Full Text] [Related]

  • 6. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
    Iturralde Codina A, Beyríe Tamayo W, Gozá León F, Muñoz YI.
    Arch Esp Urol; 2004 Aug; 57(6):606-18. PubMed ID: 15382436
    [Abstract] [Full Text] [Related]

  • 7. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH, Ye G, Wang XW, Jin HS, Zhang YN, Yan ZL.
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [Abstract] [Full Text] [Related]

  • 8. Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer.
    Saint F, Patard JJ, Irani J, Salomon L, Hoznek A, Legrand P, Debois H, Abbou CC, Chopin DK.
    Urology; 2001 Apr; 57(4):617-21; discussion 621-2. PubMed ID: 11306359
    [Abstract] [Full Text] [Related]

  • 9. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 10. Sequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors: a randomized prospective study.
    Ali-El-Dein B, Nabeeh A, Ismail EH, Ghoneim MA.
    J Urol; 1999 Aug; 162(2):339-42. PubMed ID: 10411034
    [Abstract] [Full Text] [Related]

  • 11. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF.
    Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813
    [Abstract] [Full Text] [Related]

  • 12. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
    de Reijke TM, de Boer EC, Kurth KH, Schamhart DH.
    J Urol; 1996 Feb 15; 155(2):477-82. PubMed ID: 8558640
    [Abstract] [Full Text] [Related]

  • 13. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S, Brustia D, Rosa F, Brondolo R, Rizzo G, Garavelli PL.
    Recenti Prog Med; 2002 Apr 15; 93(4):247-8. PubMed ID: 11989131
    [Abstract] [Full Text] [Related]

  • 14. Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.
    Koga H, Kuroda M, Kudo S, Yamaguchi A, Usami M, Suzuki T, Naito S.
    Int J Urol; 2005 Feb 15; 12(2):145-51. PubMed ID: 15733108
    [Abstract] [Full Text] [Related]

  • 15. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.
    Takayama H, Nishimura K, Tsujimura A, Nakai Y, Nakayama M, Aozasa K, Okuyama A, Nonomura N.
    J Urol; 2009 Apr 15; 181(4):1894-900. PubMed ID: 19237175
    [Abstract] [Full Text] [Related]

  • 16. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
    Uchida A, Yonou H, Hayashi E, Iha K, Oda M, Miyazato M, Oshiro Y, Hokama S, Sugaya K, Ogawa Y.
    Urology; 2007 Feb 15; 69(2):275-9. PubMed ID: 17320663
    [Abstract] [Full Text] [Related]

  • 17. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer.
    Kaneko T, Fujita K, Homma Y.
    Int J Urol; 2006 Mar 15; 13(3):294-5. PubMed ID: 16643629
    [Abstract] [Full Text] [Related]

  • 18. Systemic and local immunomodulatory effects of intravesical BCG therapy in patients with superficial urinary bladder carcinomas.
    Elsässer-Beile U, Gutzeit O, Bauer S, Katzenwadel A, Schultze-Seemann W, Wetterauer U.
    J Urol; 2000 Jan 15; 163(1):296-9. PubMed ID: 10604379
    [Abstract] [Full Text] [Related]

  • 19. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S, Hirao Y, BCG Tokyo 172 Strain Study Group.
    Urology; 2006 Mar 15; 67(3):545-9. PubMed ID: 16527576
    [Abstract] [Full Text] [Related]

  • 20. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW, Shen ZJ, Ding GQ.
    J Urol; 2008 Apr 15; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.